2op3: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The substrate activity screening (SAS) method, a substrate-based fragment, identification and optimization method for the development of enzyme, inhibitors, was previously applied to cathepsin S to obtain a novel, (2-arylphenoxy)acetaldehyde inhibitor, 2, with a 0.49 muM Ki value (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J., Am. Chem. Soc. 2005, 127, 15521-15527). In this paper we disclose the, X-ray structure of a complex between cathepsin S and inhibitor 2 which, reveals an unprecedented binding mode. On the basis of this structure, additional 2-biaryloxy substrates with greatly increased cleavage, efficiency were designed. Conversion of the optimized substrates to the, corresponding aldehyde inhibitors yielded a low molecular weight (304, Daltons) and potent (9.6 nM) cathepsin S inhibitor that showed from 100-, to >1000-fold selectivity relative to cathepsins B, L, and K.
The substrate activity screening (SAS) method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain a novel (2-arylphenoxy)acetaldehyde inhibitor, 2, with a 0.49 microM Ki value (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527). In this paper we disclose the X-ray structure of a complex between cathepsin S and inhibitor 2 which reveals an unprecedented binding mode. On the basis of this structure, additional 2-biaryloxy substrates with greatly increased cleavage efficiency were designed. Conversion of the optimized substrates to the corresponding aldehyde inhibitors yielded a low molecular weight (304 Daltons) and potent (9.6 nM) cathepsin S inhibitor that showed from 100- to >1000-fold selectivity relative to cathepsins B, L, and K.


==About this Structure==
==About this Structure==
Line 10: Line 10:


==Reference==
==Reference==
Characterization and Optimization of Selective, Nonpeptidic Inhibitors of Cathepsin S with an Unprecedented Binding Mode., Inagaki H, Tsuruoka H, Hornsby M, Lesley SA, Spraggon G, Ellman JA, J Med Chem. 2007 May 1;. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17469812 17469812]
Characterization and optimization of selective, nonpeptidic inhibitors of cathepsin S with an unprecedented binding mode., Inagaki H, Tsuruoka H, Hornsby M, Lesley SA, Spraggon G, Ellman JA, J Med Chem. 2007 May 31;50(11):2693-9. Epub 2007 May 1. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=17469812 17469812]
[[Category: Cathepsin S]]
[[Category: Cathepsin S]]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Ellman, J.A.]]
[[Category: Ellman, J A.]]
[[Category: Hornsby, M.]]
[[Category: Hornsby, M.]]
[[Category: Inagaki, H.]]
[[Category: Inagaki, H.]]
[[Category: Lesley, S.A.]]
[[Category: Lesley, S A.]]
[[Category: Spraggon, G.]]
[[Category: Spraggon, G.]]
[[Category: Tsuruoka, H.]]
[[Category: Tsuruoka, H.]]
Line 27: Line 27:
[[Category: substrate activity screening]]
[[Category: substrate activity screening]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 13:56:50 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:21:00 2008''